Mycophenolate mofetil (MMF) does not slow the progression of subclinical atherosclerosis in SLE over 2 years

Adnan K. Kiani, Michelle Petri, Laurence S. Magder

Research output: Contribution to journalArticlepeer-review

23 Scopus citations

Fingerprint

Dive into the research topics of 'Mycophenolate mofetil (MMF) does not slow the progression of subclinical atherosclerosis in SLE over 2 years'. Together they form a unique fingerprint.

Medicine & Life Sciences